Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMM Study: Palliative Radiotherapy Before Systemic Therapy in Metastatic NSCLC
NCT05440916Phase 2Completed
- Sponsor
- University Clinical Centre Maribor
- Start
- Jul 2022
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 2, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University Clinical Centre Maribor. Primary endpoint: Progression Free Survival at 18 months. Started Jul 2022; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05440916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05440916.